Bayer wins OK for hemophilia A treatment; Agenus sells off a slice of future royalties for $15M
→ Japanese officials have approved Bayer’s hemophilia A drug Jivi (BAY94-9027), a Factor VIII treatment.
→ Xoma is tapping into their line of credit …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
